ES
Eagle Strategies’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.55M | Sell |
12,239
-561
| -4% | -$71K | 0.24% | 87 |
|
|
2025
Q1 | $1.64M | Buy |
12,800
+1,181
| +10% | +$151K | 0.28% | 71 |
|
|
2024
Q4 | $1.54M | Buy |
11,619
+354
| +3% | +$46.8K | 0.27% | 73 |
|
|
2024
Q3 | $1.64M | Sell |
11,265
-409
| -4% | -$59.6K | 0.3% | 70 |
|
|
2024
Q2 | $1.6M | Buy |
11,674
+9,883
| +552% | +$1.36M | 0.31% | 71 |
|
|
2024
Q1 | $246K | Sell |
1,791
-9,297
| -84% | -$1.28M | 0.05% | 236 |
|
|
2023
Q4 | $1.51M | Sell |
11,088
-75
| -0.7% | -$10.2K | 0.32% | 67 |
|
|
2023
Q3 | $1.37M | Buy |
11,163
+646
| +6% | +$79K | 0.34% | 66 |
|
|
2023
Q2 | $1.34M | Buy |
10,517
+143
| +1% | +$18.2K | 0.32% | 68 |
|
|
2023
Q1 | $1.34M | Buy |
10,374
+211
| +2% | +$27.3K | 0.33% | 62 |
|
|
2022
Q4 | $1.33M | Buy |
10,163
+515
| +5% | +$67.6K | 0.4% | 59 |
|
|
2022
Q3 | $1.13M | Buy |
9,648
+1,289
| +15% | +$151K | 0.59% | 41 |
|
|
2022
Q2 | $983K | Buy |
8,359
+4,101
| +96% | +$482K | 0.36% | 60 |
|
|
2022
Q1 | $555K | Sell |
4,258
-7,488
| -64% | -$976K | 0.22% | 79 |
|
|
2021
Q4 | $1.79M | Buy |
+11,746
| New | +$1.79M | 0.7% | 39 |
|